- Home
- Publications
- Publication Search
- Publication Details
Title
FGF/FGFR Pathways in Multiple Sclerosis and in Its Disease Models
Authors
Keywords
-
Journal
Cells
Volume 10, Issue 4, Pages 884
Publisher
MDPI AG
Online
2021-04-13
DOI
10.3390/cells10040884
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CD36-mediated uptake of myelin debris by macrophages and microglia reduces neuroinflammation
- (2020) Elien Grajchen et al. Journal of Neuroinflammation
- Dimethyl fumarate vs Teriflunomide: an Italian time-to-event data analysis
- (2020) Emanuele D’Amico et al. JOURNAL OF NEUROLOGY
- Ofatumumab versus Teriflunomide in Multiple Sclerosis
- (2020) Stephen L. Hauser et al. NEW ENGLAND JOURNAL OF MEDICINE
- Gsta4 controls apoptosis of differentiating adult oligodendrocytes during homeostasis and remyelination via the mitochondria-associated Fas-Casp8-Bid-axis
- (2020) Karl E. Carlström et al. Nature Communications
- Oligodendrocyte Physiology and Pathology Function
- (2020) Markus Kipp Cells
- Oligodendrocyte‐specific deletion of FGFR2 ameliorates MOG 35‐55 ‐induced EAE through ERK and Akt signalling
- (2020) Salar Kamali et al. BRAIN PATHOLOGY
- Association of Rituximab Treatment With Disability Progression Among Patients With Secondary Progressive Multiple Sclerosis
- (2019) Yvonne Naegelin et al. JAMA Neurology
- Altered human oligodendrocyte heterogeneity in multiple sclerosis
- (2019) Sarah Jäkel et al. NATURE
- Placing CD20-targeted B cell depletion in multiple sclerosis therapeutic scenario: Present and future perspectives
- (2019) Emanuele D'Amico et al. AUTOIMMUNITY REVIEWS
- Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trial
- (2019) Diego Cadavid et al. LANCET NEUROLOGY
- Review: Patient-reported outcomes in multiple sclerosis care
- (2019) Emanuele D'Amico et al. Multiple Sclerosis and Related Disorders
- Microglia Biology: One Century of Evolving Concepts
- (2019) Marco Prinz et al. CELL
- Safety and efficacy of ozanimod versus interferon beta-1a in relapsing multiple sclerosis (RADIANCE): a multicentre, randomised, 24-month, phase 3 trial
- (2019) Jeffrey A Cohen et al. LANCET NEUROLOGY
- IL-17+ CD8+ T cell suppression by dimethyl fumarate associates with clinical response in multiple sclerosis
- (2019) Christina Lückel et al. Nature Communications
- Polarizing receptor activation dissociates fibroblast growth factor 2 mediated inhibition of myelination from its neuroprotective potential
- (2019) Katja Thümmler et al. Acta Neuropathologica Communications
- Late onset and young onset relapsing remitting multiple sclerosis. Evidence from a retrospective long-term follow-up study
- (2018) Emanuele D'Amico et al. EUROPEAN JOURNAL OF NEUROLOGY
- Role of mitochondrial ROS in the brain: from physiology to neurodegeneration
- (2018) Plamena R. Angelova et al. FEBS LETTERS
- Multiple sclerosis
- (2018) Alan J Thompson et al. LANCET
- Multiple Sclerosis
- (2018) Daniel S. Reich et al. NEW ENGLAND JOURNAL OF MEDICINE
- Multiple Sclerosis Pathology
- (2018) Hans Lassmann Cold Spring Harbor Perspectives in Medicine
- Glia-neuron energy metabolism in health and diseases: New insights into the role of nervous system metabolic transporters
- (2018) Mithilesh Kumar Jha et al. EXPERIMENTAL NEUROLOGY
- Initial Impairment and Recovery of Vision-Related Functioning in Participants With Acute Optic Neuritis From the RENEW Trial of Opicinumab
- (2018) Jennifer Petrillo et al. JOURNAL OF NEURO-OPHTHALMOLOGY
- How Do Cells of the Oligodendrocyte Lineage Affect Neuronal Circuits to Influence Motor Function, Memory and Mood?
- (2018) Renee E. Pepper et al. Frontiers in Cellular Neuroscience
- Effectiveness and safety of Rituximab in demyelinating diseases spectrum: An Italian experience
- (2018) Emanuele D'Amico et al. Multiple Sclerosis and Related Disorders
- Signaling by FGF Receptor 2, Not FGF Receptor 1, Regulates Myelin Thickness through Activation of ERK1/2–MAPK, Which Promotes mTORC1 Activity in an Akt-Independent Manner
- (2017) Miki Furusho et al. JOURNAL OF NEUROSCIENCE
- Safety and efficacy of opicinumab in acute optic neuritis (RENEW): a randomised, placebo-controlled, phase 2 trial
- (2017) Diego Cadavid et al. LANCET NEUROLOGY
- New insights into the burden and costs of multiple sclerosis in Europe: Results for Germany
- (2017) Peter Flachenecker et al. Multiple Sclerosis Journal
- Regenerating CNS myelin — from mechanisms to experimental medicines
- (2017) Robin J. M. Franklin et al. NATURE REVIEWS NEUROSCIENCE
- Assessing association of comorbidities with treatment choice and persistence in MS
- (2017) Alice Laroni et al. NEUROLOGY
- Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
- (2017) Stephen L. Hauser et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis
- (2017) Xavier Montalban et al. NEW ENGLAND JOURNAL OF MEDICINE
- New insights into the burden and costs of multiple sclerosis in Europe: Results for Germany
- (2017) Peter Flachenecker et al. Multiple Sclerosis Journal
- Multiple sclerosis: experimental models and reality
- (2016) Hans Lassmann et al. ACTA NEUROPATHOLOGICA
- Treatment-Related Progressive Multifocal Leukoencephalopathy in Multiple Sclerosis: A Comprehensive Review of Current Evidence and Future Needs
- (2016) Emanuele D’Amico et al. DRUG SAFETY
- The role of growth factors as a therapeutic approach to demyelinating disease
- (2016) Yangyang Huang et al. EXPERIMENTAL NEUROLOGY
- Antiglutamatergic therapy for multiple sclerosis?
- (2016) Reinhard Hohlfeld et al. LANCET NEUROLOGY
- Can we define a rehabilitation strategy for cognitive impairment in progressive multiple sclerosis? A critical appraisal
- (2016) Emanuele D’Amico et al. Multiple Sclerosis Journal
- Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis
- (2016) Tomas Olsson et al. Nature Reviews Neurology
- Can we define a rehabilitation strategy for cognitive impairment in progressive multiple sclerosis? A critical appraisal
- (2016) Emanuele D’Amico et al. Multiple Sclerosis Journal
- Fibroblast growth factor signalling in multiple sclerosis: inhibition of myelination and induction of pro-inflammatory environment by FGF9
- (2015) Maren Lindner et al. BRAIN
- Distinct sets of FGF receptors sculpt excitatory and inhibitory synaptogenesis
- (2015) A. Dabrowski et al. DEVELOPMENT
- Fibroblast growth factor signaling in oligodendrocyte-lineage cells facilitates recovery of chronically demyelinated lesions but is redundant in acute lesions
- (2015) Miki Furusho et al. GLIA
- Inefficient clearance of myelin debris by microglia impairs remyelinating processes
- (2015) Antoine Lampron et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Role of the innate and adaptive immune responses in the course of multiple sclerosis
- (2015) Bernhard Hemmer et al. LANCET NEUROLOGY
- Exploring the origins of grey matter damage in multiple sclerosis
- (2015) Massimiliano Calabrese et al. NATURE REVIEWS NEUROSCIENCE
- The Fibroblast Growth Factor signaling pathway
- (2015) David M. Ornitz et al. Wiley Interdisciplinary Reviews-Developmental Biology
- Revised diagnostic criteria of multiple sclerosis
- (2014) Ron Milo et al. AUTOIMMUNITY REVIEWS
- Mechanisms of white matter damage in multiple sclerosis
- (2014) Hans Lassmann GLIA
- Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial
- (2014) Peter A Calabresi et al. LANCET NEUROLOGY
- Transcript profiling of different types of multiple sclerosis lesions yields FGF1 as a promoter of remyelination
- (2014) Hema Mohan et al. Acta Neuropathologica Communications
- Fibroblast Growth Factor-2 Signaling in Neurogenesis and Neurodegeneration
- (2013) Maya E. Woodbury et al. Journal of Neuroimmune Pharmacology
- FGF2 and FGFR1 signaling regulate functional recovery following cuprizone demyelination
- (2013) Amanda J. Mierzwa et al. NEUROSCIENCE LETTERS
- The mechanism of action of glatiramer acetate in multiple sclerosis and beyond
- (2012) Rina Aharoni AUTOIMMUNITY REVIEWS
- Rejuvenation of Regeneration in the Aging Central Nervous System
- (2012) Julia M. Ruckh et al. Cell Stem Cell
- Fibroblast Growth Factor Receptor Signaling in Oligodendrocytes Regulates Myelin Sheath Thickness
- (2012) M. Furusho et al. JOURNAL OF NEUROSCIENCE
- Neuroprotection and repair in multiple sclerosis
- (2012) Robin J. M. Franklin et al. Nature Reviews Neurology
- Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis
- (2012) Robert J. Fox et al. NEW ENGLAND JOURNAL OF MEDICINE
- Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis
- (2012) Ralf Gold et al. NEW ENGLAND JOURNAL OF MEDICINE
- Capture, crawl, cross: the T cell code to breach the blood–brain barriers
- (2012) Britta Engelhardt et al. TRENDS IN IMMUNOLOGY
- Frequency and severity of headache is worsened by Interferon-β therapy in patients with multiple sclerosis
- (2011) F. Patti et al. ACTA NEUROLOGICA SCANDINAVICA
- Enhancing remyelination in disease--can we wrap it up?
- (2011) M. R. Kotter et al. BRAIN
- Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS)
- (2011) Cris S Constantinescu et al. BRITISH JOURNAL OF PHARMACOLOGY
- Multiple sclerosis as a neurodegenerative disease: pathology, mechanisms and therapeutic implications
- (2011) Christine Stadelmann CURRENT OPINION IN NEUROLOGY
- Serum and CSF PDGF-AA and FGF-2 in relapsing-remitting multiple sclerosis: a case-control study
- (2011) M. H. Harirchian et al. EUROPEAN JOURNAL OF NEUROLOGY
- Neuroprotective role of fibroblast growth factor-2 in experimental autoimmune encephalomyelitis
- (2011) Andrea Rottlaender et al. IMMUNOLOGY
- FGF-2 and Anosmin-1 Are Selectively Expressed in Different Types of Multiple Sclerosis Lesions
- (2011) D. Clemente et al. JOURNAL OF NEUROSCIENCE
- Fibroblast Growth Factor Signaling Is Required for the Generation of Oligodendrocyte Progenitors from the Embryonic Forebrain
- (2011) M. Furusho et al. JOURNAL OF NEUROSCIENCE
- Meningeal T cells associate with diffuse axonal loss in multiple sclerosis spinal cords
- (2010) Géraldine Androdias et al. ANNALS OF NEUROLOGY
- Evidence for a two-stage disability progression in multiple sclerosis
- (2010) E. Leray et al. BRAIN
- Treatment options of cognitive impairment in multiple sclerosis
- (2010) Francesco Patti et al. NEUROLOGICAL SCIENCES
- A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis
- (2010) Ludwig Kappos et al. NEW ENGLAND JOURNAL OF MEDICINE
- Animal models of multiple sclerosis—Potentials and limitations
- (2010) Eilhard Mix et al. PROGRESS IN NEUROBIOLOGY
- Rituximab in patients with primary progressive multiple sclerosis: Results of a randomized double-blind placebo-controlled multicenter trial
- (2009) Kathleen Hawker et al. ANNALS OF NEUROLOGY
- The relation between inflammation and neurodegeneration in multiple sclerosis brains
- (2009) Josa M. Frischer et al. BRAIN
- Virtual hypoxia and chronic necrosis of demyelinated axons in multiple sclerosis
- (2009) Bruce D Trapp et al. LANCET NEUROLOGY
- Remyelination protects axons from demyelination-associated axon degeneration
- (2008) K. A. Irvine et al. BRAIN
- Differentiation block of oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple sclerosis
- (2008) T. Kuhlmann et al. BRAIN
- The biology of CNS remyelination
- (2008) Robin J. M. Franklin et al. JOURNAL OF NEUROLOGY
- Remyelination in the CNS: from biology to therapy
- (2008) Robin J. M. Franklin et al. NATURE REVIEWS NEUROSCIENCE
- Fibroblast growth factor-2 levels are elevated in the cerebrospinal fluid of multiple sclerosis patients
- (2008) Paola Sarchielli et al. NEUROSCIENCE LETTERS
- B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis
- (2008) Stephen L. Hauser et al. NEW ENGLAND JOURNAL OF MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started